List of works by Sebastian Stintzing

A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials

scientific article published on 04 October 2016

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial

scientific article

A small cog in a big wheel: PIK3CA mutations in colorectal cancer.

scientific article published on 14 November 2013

AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3

scientific article published on 26 March 2019

Amphiregulin expression is a predictive biomarker for EGFR inhibition in metastatic colorectal cancer: combined analysis of three randomized trials

scientific article published on 17 September 2020

Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancer

scientific article

Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study

scientific article published on 10 May 2018

Author's reply to: "Prognostic value of cetuximab related skintoxicity in metastatic colorectal cancer patients and its correlation with parameters of the EGFR signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study

scientific article published on 18 September 2012

CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy

scientific article published on 9 August 2016

Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer

scientific article

Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone

scientific article published on 13 January 2013

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

scientific article published on 01 November 2019

Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial

scientific article

Cyberknife surgery with a radio-scalpel: a new treatment option for patients with unresectable metastases

scientific article

Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate.

scientific article published in May 2003

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer

scientific article published on 01 May 2020

Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: an analysis of the German AIO KRK 0104 trial

scientific article published on 18 December 2012

Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer

scientific article published on 07 November 2018

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306

scientific article published on 04 January 2012

Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trials

scientific article published in 2022

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer

scientific article

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases.

scientific article published on 17 February 2015

Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials

scientific article published on 2 August 2017

Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3

scientific article published on 07 March 2019

Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.

scientific article

Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society

scientific article published on 16 December 2020

KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer.

scientific article published on 2 March 2013

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association

scientific article published on 01 December 2020

MicroRNA-21 in colorectal cancer: "Just another brick in the wall"?

scientific article published on 23 May 2013

Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?

scientific article

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

scientific article

Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment)

scientific article published on 01 February 2014

Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis.

scientific article published on May 2005

Percutaneous radiofrequency ablation (RFA) or robotic radiosurgery (RRS) for salvage treatment of colorectal liver metastases.

scientific article published on 14 February 2013

Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.

scientific article published on 29 October 2013

Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients

scientific article published on 13 October 2020

Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer

scientific article published on 21 June 2018

Primary testicular lymphoma: a strictly homogeneous hematological disease?

scientific article

Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group.

scientific article published on 14 October 2013

Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO C

scientific article published on 26 June 2012

Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials

scientific article published on 13 November 2012

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!

scientific article

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Radiosurgery of liver tumors: value of robotic radiosurgical device to treat liver tumors.

scientific article published on 24 June 2010

Recent advances in understanding colorectal cancer

scientific article published on 24 September 2018

Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

scientific article published on 27 November 2018

Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial

scientific article

Role of cannabinoid receptors and RAGE in inflammatory bowel disease.

scientific article

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study

scientific article published on 26 October 2020

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models

scientific article published on 16 July 2021

Targeted therapies: Cetuximab dosing by rash--is the scaling of EVEREST meaningful?

scientific article published on 14 August 2012

The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: an analysis of the AIO KRK-0104-trial

scientific article published on 17 November 2011

The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials.

scientific article

The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status.

scientific article published on 20 March 2009

Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives

scientific article

Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment inRASWild-Type Metastatic Colorectal Cancer

scientific article published on 14 August 2018

[CA 19-9 in the differential diagnosis of pancreatic lesions]

scientific article published on 01 February 2008

[Colon cancer: adjuvant chemotherapy and aftercare]

scientific article published on 01 September 2011